2.07
price up icon3.50%   0.07
after-market 시간 외 거래: 2.10 0.03 +1.45%
loading
전일 마감가:
$2.00
열려 있는:
$1.98
하루 거래량:
459.93K
Relative Volume:
0.41
시가총액:
$100.05M
수익:
-
순이익/손실:
$-123.46M
주가수익비율:
-0.7964
EPS:
-2.5993
순현금흐름:
$-104.11M
1주 성능:
+2.99%
1개월 성능:
-5.91%
6개월 성능:
-36.31%
1년 성능:
+11.89%
1일 변동 폭
Value
$1.95
$2.095
1주일 범위
Value
$1.92
$2.15
52주 변동 폭
Value
$1.14
$4.02

바이오아틀라 Stock (BCAB) Company Profile

Name
명칭
Bioatla Inc
Name
전화
858-558-0708
Name
주소
11085 TORREYANA ROAD, SAN DIEGO
Name
직원
65
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
BCAB's Discussions on Twitter

바이오아틀라 Stock (BCAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-09-15 개시 JMP Securities Mkt Outperform
2022-05-05 다운그레이드 Credit Suisse Outperform → Neutral
2022-03-21 개시 H.C. Wainwright Buy
2021-10-15 재개 BTIG Research Buy
2021-06-28 개시 ROTH Capital Buy
2021-05-05 재개 Credit Suisse Outperform
2021-04-26 재개 Credit Suisse Outperform
2021-01-11 개시 BTIG Research Buy
2021-01-11 개시 Credit Suisse Outperform
2021-01-11 개시 JP Morgan Overweight
2021-01-11 개시 Jefferies Buy
모두보기

바이오아틀라 주식(BCAB)의 최신 뉴스

pulisher
Oct 31, 2024

BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024 - The Manila Times

Oct 31, 2024
pulisher
Oct 30, 2024

BioAtla, Inc. (NASDAQ:BCAB) has caught the attention of institutional investors who hold a sizeable 39% stake - Yahoo Finance UK

Oct 30, 2024
pulisher
Oct 28, 2024

BioAtla, Inc. (NASDAQ:BCAB) Short Interest Update - MarketBeat

Oct 28, 2024
pulisher
Oct 20, 2024

BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading Into 2025 - Insider Monkey

Oct 20, 2024
pulisher
Oct 15, 2024

You might want to take a look at BioAtla Inc (BCAB) now - SETE News

Oct 15, 2024
pulisher
Oct 14, 2024

BioAtla Inc (BCAB) stock: A year of ups and downs - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Market Insights: BioAtla Inc (BCAB)’s Notable Gain of 7.25, Closing at 2.07 - The Dwinnex

Oct 14, 2024
pulisher
Oct 13, 2024

636,136 Shares in BioAtla, Inc. (NASDAQ:BCAB) Acquired by AQR Capital Management LLC - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

AQR Capital Management LLC Makes New Investment in BioAtla, Inc. (NASDAQ:BCAB) - MarketBeat

Oct 13, 2024
pulisher
Oct 09, 2024

There is no doubt that BioAtla Inc (BCAB) ticks all the boxes. - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

Bank of Montreal Can Buys 143,521 Shares of BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Oct 09, 2024
pulisher
Oct 08, 2024

BioAtla's FDA Fast-Tracked Drug Candidate Boosts Its Oncology Prospects, Speculative Buy - Seeking Alpha

Oct 08, 2024
pulisher
Oct 08, 2024

Renaissance Technologies LLC Sells 370,800 Shares of BioAtla, Inc. (NASDAQ:BCAB) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

BioAtla: Numerous Catalysts Coming In Q4 (NASDAQ:BCAB) - Seeking Alpha

Oct 07, 2024
pulisher
Oct 07, 2024

Analyzing the Impact of Earnings Reports on BioAtla Inc Inc. (BCAB) Price Performance - The InvestChronicle

Oct 07, 2024
pulisher
Oct 07, 2024

BioAtla to Score Up to $133M - San Diego Business Journal

Oct 07, 2024
pulisher
Oct 07, 2024

Should investors be concerned about BioAtla Inc (BCAB)? - US Post News

Oct 07, 2024
pulisher
Oct 06, 2024

BioAtla to Host Virtual R&D Day on Clinical Program and Pipeline Updates on July 25, 2024 - Quantisnow

Oct 06, 2024
pulisher
Oct 04, 2024

BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - ForexTV.com

Oct 04, 2024
pulisher
Oct 03, 2024

Pleasing Signs As A Number Of Insiders Buy BioAtla Stock - Simply Wall St

Oct 03, 2024
pulisher
Oct 02, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Oct 02, 2024
pulisher
Oct 02, 2024

JMP Securities gives a Mkt outperform recommendation for BioAtla Inc (BCAB) - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Rhumbline Advisers Cuts Stock Position in BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Oct 02, 2024
pulisher
Oct 01, 2024

Potential Price Increase for Equinix Inc (EQIX) After Recent Insider Activity - Knox Daily

Oct 01, 2024
pulisher
Oct 01, 2024

BCAB’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Oct 01, 2024
pulisher
Oct 01, 2024

Analyzing BCAB’s price-to-book ratio for the last quarter - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

Michael Burry buys 634,000 shares of this $1 penny stockFinbold - Finbold - Finance in Bold

Oct 01, 2024
pulisher
Oct 01, 2024

BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress - The Manila Times

Oct 01, 2024
pulisher
Sep 30, 2024

BioAtla Inc (BCAB)’s financial ratios: A comprehensive overview - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

A new trading data show BioAtla Inc (BCAB) is showing positive returns. - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

XTX Topco Ltd Trims Stock Position in BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Michael Burry just bought 633,959 shares in this $1 penny stock - Motley Fool UK

Sep 30, 2024
pulisher
Sep 28, 2024

Scion Asset Management LLC Purchases Shares of 633,959 BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Sep 28, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: BioAtla stockInnovative cancer therapy faces pivotal year - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

BCAB’s valuation metrics: A comprehensive analysis - US Post News

Sep 27, 2024
pulisher
Sep 27, 2024

Scion Asset Management LLC Purchases New Holdings in BioAtla, Inc. (NASDAQ:BCAB) - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Century Therapeutics (NASDAQ:IPSC) & BioAtla (NASDAQ:BCAB) Financial Comparison - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

BioAtla and Context Therapeutics Forge Strategic Agreement for Cancer Treatment Development - MSN

Sep 26, 2024
pulisher
Sep 25, 2024

BioAtla - The Pharma Letter

Sep 25, 2024
pulisher
Sep 24, 2024

Analyzing Bio-Techne Corp (TECH) After Recent Trading Activity - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

BlackRock Capital Allocation Term Trust (NYSE:BCAT) Major Shareholder Saba Capital Management, L.P. Sells 33,209 Shares - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

BioAtla out-licenses T cell therapy in $134 million deal - The Pharma Letter

Sep 24, 2024
pulisher
Sep 24, 2024

(BTMD) Technical Pivots with Risk Controls - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 23, 2024

BioAtla licenses cancer drug candidate to Context Therapeutics By Investing.com - Investing.com Canada

Sep 23, 2024
pulisher
Sep 23, 2024

BioAtla licenses cancer drug candidate to Context Therapeutics - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Ventyx deal a sign of Sanofi’s growing interest neuro-immunology? - BioCentury

Sep 23, 2024
pulisher
Sep 23, 2024

Dawson James downgrades BioCardia Inc. (BCDA) stock to a Neutral - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Context Therapeutics signs second multimillion-dollar licensing deal in 3 months - The Business Journals

Sep 23, 2024
pulisher
Sep 23, 2024

BlackRock Capital Allocation Term Trust (NYSE:BCAT) Major Shareholder Sells $245,706.93 in Stock - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

SickKids names FCB Canada new AOR - Strategy Online

Sep 23, 2024
pulisher
Sep 23, 2024

Context builds up bank of bispecific antibodies with up to $133M biobucks deal for BioAtla asset - Fierce Biotech

Sep 23, 2024

바이오아틀라 (BCAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

바이오아틀라 주식 (BCAB) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
SHORT JAY M PHD
Chief Executive Officer
Dec 20 '23
Buy
2.14
50,000
106,910
1,439,283
STEINMAN LAWRENCE
Director
Dec 19 '23
Buy
2.05
20,000
41,048
38,459
Vasquez Christian
See Remarks
Dec 19 '23
Buy
2.04
7,495
15,262
115,659
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):